US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024

This cross-sectional study examines trends in prescribing nonstatin lipid-lowering therapy in the US from 2019 to 2024 vs statin prescribing.

Authors

Institutions

Publication Details

Journal
JAMA Cardiology
Published
2026-04-22
DOI
https://doi.org/10.1001/jamacardio.2026.0844
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024

Yara Jelwan, Semenawit Burka, John Erhabor, Michael J. Blaha et al.
JAMA Cardiology
Lipoproteins and Cardiovascular Health
article

US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024

Yara Jelwan, Semenawit Burka, John Erhabor, Michael J. Blaha, Khurram Nasir, Maciej Banach, Omar Dzaye, Tianyu Cao
article en

Abstract

This cross-sectional study examines trends in prescribing nonstatin lipid-lowering therapy in the US from 2019 to 2024 vs statin prescribing.

JAMA Cardiology
Houston Methodist (US), Johns Hopkins University (US), Medical University of Lodz (PL)
Openalex Percentile: Top 11%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.